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Coagulase-negative staphylococci have been recognised both as emerging pathogens and 46 
contaminants of clinical samples.  High resolution genomic investigation may provide 47 
insights into their clinical significance. 48 
Aims 49 
To review the literature regarding coagulase-negative staphylococcal infection and the 50 
utility of genomic methods to aid diagnosis and management and to identify promising 51 
areas for future research. 52 
Methodology 53 
We searched Google Scholar with the terms (Staphylococcus) AND (sequencing OR 54 
(infection)).  We prioritised papers which addressed coagulase-negative staphylococci, 55 
genomic analysis, or infection. 56 
Results 57 
A number of studies have investigated specimen-related, phenotypic and genetic factors 58 
associated with colonisation, infection and virulence, but diagnosis remains problematic. 59 
Conclusion 60 
Genomic investigation provides insights into genetic diversity and natural history of 61 
colonisation and infection. Such information allows the development of new 62 
methodologies to identify and compare relatedness and predict antimicrobial resistance. 63 
Future clinical studies that employ suitable sampling frames coupled with the application 64 
of high-resolution whole genome sequencing may aid the development of more 65 
discriminatory diagnostic approaches to coagulase-staphylococcal infection. 66 
 67 
Introduction 68 
The term “Staphylococcus” was introduced by Sir Alexander Ogston to describe grape-like 69 
clusters of bacteria associated with post-surgical infection (1). Friedrich Rosenbach 70 
adopted the name when in 1884 he described “Staphylococcus pyogenes aureus” and 71 
“Staphylococcus pyogenes albus” (2). Both forms, differentiated by their golden and white 72 
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colony pigmentation, were considered by the early authors to be bona fide pathogens. In 73 
1891, Welch reported the recovery of apparently non-pathogenic strains from the 74 
epidermis and from aseptic wounds, which he called “Staphylococcus epidermidis albus” 75 
(3). In 1940, Fairbrother noted that coagulase activity could be used to differentiate S. 76 
aureus from generally less pathogenic coagulase-negative staphylococci (4). Until the 77 
1970s, the names “S. albus” and S. epidermidis were applied widely to coagulase-negative 78 
staphylococci (CoNS) (5). Novel staphylococci continue to be described (6,7) and at the 79 
time of writing the genus Staphylococcus comprises 55 validly published separate species 80 
plus an additional 12 separate subspecies, among which, S. aureus is preeminent as a 81 
pathogen of humans (8). In clinical practice the distinction between coagulase-positive (S. 82 
aureus and related species such as S. intermedius) and coagulase-negative (mostly low-83 
virulence organisms, including S. epidermidis) staphylococci remains important. 84 
 85 
Coagulase-negative staphylococci: colonisation and infection 86 
In contrast with S. aureus which is associated with a wide range of community-acquired 87 
and nosocomial syndromes of infection, CoNS species are generally considered to be low-88 
virulence organisms and less significant as causes of human disease. However, two CoNS 89 
species are associated with distinctive disease profiles. Unlike other staphylococci 90 
Staphylococcus saprophyticus possesses ion transport systems and adhesins which allow it 91 
to colonise the lower urinary tract (9) and this species is a common cause of urinary tract 92 
infection among young women (10). Staphylococcus lugdunensis, a commensal of inguinal 93 
and axillary skin, displays virulence mechanisms similar to S. aureus including an iron 94 
capture system, adhesins (fibronectin binding proteins) and biofilm formation. S. 95 
lugdunensis causes a spectrum of serious infections similar to S. aureus including 96 
endocarditis and osteomyelitis (11). However, clustered, regularly interspaced, short 97 
palindromic repeats (CRISPR) and restriction-modification systems limit its uptake of 98 
mobile genetic elements and associated virulence and antimicrobial resistance genes (12–99 
14). Both species have been recently reviewed and will not be considered further (15,16). 100 
Other CoNS species are found extensively amongst humans, animals and the environment. 101 
Some are ubiquitous commensals of human skin and mucosal surfaces (17). As many as 18 102 
different species have been cultured from the skin of healthy adults at densities of 10 to 103 
103 colony-forming units per cm2 (17,18). Staphylococcus epidermidis is the species most 104 
commonly identified in diagnostic microbiology accounting for over half of all CoNS 105 
Page 4 of 43 
 
isolates across published series (Table 1), while S. haemolyticus, S. hominis and S. capitis, 106 
collectively account for over a quarter of isolates. Although usually identified in diagnostic 107 
microbiology as specimen contaminants, these species can also represent pathogens in 108 
certain patient groups. They have been termed ‘accidental’ pathogens (19) or ‘Pathogens 109 
Associated with Medical Progress’ (20) due to their ability to establish infection in the 110 
context of implanted medical devices. The infections they cause are typically indolent and 111 
complicate invasive hospital procedures such as the insertion of intravenous catheters and 112 
the implantation of biosynthetic materials. Coagulase-negative staphylococci are common 113 
causes of biomaterial infections including vascular grafts, prosthetic heart valves, cardiac 114 
pacemakers, central nervous system shunts, continuous ambulatory peritoneal dialysis and 115 
urinary catheters (5,16,18,21–24). Occasionally they cause native tissue infections 116 
including native-valve endocarditis, osteomyelitis, otitis media, ocular infections and 117 
surgical-site infections (10,22,25,26). Antibiotic resistance is widespread among CoNS 118 
species. Rates of methicillin resistance in clinical isolates can be as high as 80 % for S. 119 
epidermidis and other species (27–29) and in many healthcare settings are higher than for 120 
S. aureus (28,30,31). Resistance to other antimicrobials is increasing amongst clinical 121 
isolates of CoNS (28,32). As CoNS are common specimen contaminants, are important 122 
nosocomial pathogens and often resistant to many antibiotic classes, the interpretation of 123 
their significance in clinical specimens from normally sterile sites is a challenging problem 124 
which may require combined information from microbiological, histological and clinical 125 
investigations. 126 
 127 
Virulence of coagulase-negative staphylococci 128 
A considerable body of research has established the wide-ranging mechanisms that allow 129 
S. epidermidis and other CoNS to colonise and cause disease. These have been reviewed 130 
elsewhere (19,33–35). Many are analogous to mechanisms described for S. aureus and 131 
include immune evasion through cellular internalisation and persistence, protection from 132 
host antimicrobial peptides, adhesion to host matrix proteins, biofilm formation and 133 
antimicrobial resistance.  134 
Investigation of strain differences has successfully identified mechanisms of nosocomial 135 
adaptation. Biofilm formation is associated with nosocomial infection and hospital 136 
endemicity (19,22,35–38). Polysaccharide intercellular adhesin (PIA) encoded by the 137 
icaADBC operon is a key factor for formation of the cellular aggregations and protective 138 
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extracellular matrix that comprise the biofilm (37,39,40). The icaADBC operon is more 139 
frequently present in nosocomial than community isolates of S. epidermidis (29,36,41–46). 140 
The icaR regulatory gene is found upstream of icaADBC, and is one factor controlling its 141 
regulation allowing for phase-variability (47). The insertion sequence IS256 plays an 142 
important role in the regulation of the ica gene locus expression and PIA formation 143 
(33,48). IS256 has been found more frequently amongst nosocomial than community 144 
isolates (36,42–44,46). However, the ica locus does not always confer a PIA-producing 145 
phenotype (40,47,49,50) and biofilm formation is not completely reliant on PIA production 146 
(40,49,51). The accumulation-associated protein (aap) and Bap-homologous protein (bhp) 147 
genes present in some strains of S. epidermidis respectively encode proteins Aap and Bhp 148 
that are associated with PIA-independent biofilm formation (51–54). Both the aap and bhp 149 
genes have been detected with similar frequency amongst infecting, hospital carriage and 150 
community carriage isolates (36,42,44,45). However, Post et al. (55) reported that the 151 
presence of bhp was significantly associated with a failed treatment outcome for S. 152 
epidermidis orthopaedic device-related infections and may be the result of rapid primary 153 
attachment to abiotic surfaces during the early stages of biofilm formation. The Arginine 154 
Catabolic Mobile Element (ACME) is associated with the epidemic strain of S. aureus 155 
USA300 and encodes several putative virulence factors (56). However, in S. epidermidis it 156 
occurs at equal or higher rates in community strains compared with hospital-related 157 
strains (36,57). Moreover, Granslo et al. (56) found that the presence of the ACME was not 158 
associated with an increased inflammatory response in isolates of S. epidermidis obtained 159 
from neonate blood cultures (56). The formate-dehydrogenase (fdh) gene has been 160 
proposed as a genetic marker of commensalism due its higher prevalence in non-infecting 161 
isolates than clinical isolates of S. epidermidis (46). However, as fdh is infrequently 162 
detected even among community strains, its value as an indicator of commensalism 163 
appears at best to be limited (36).  164 
Pan-genome analyses of S. epidermidis and S. haemolyticus show that their genomes 165 
comprise 20 % and 25 % respectively of accessory genes (46,58). This open genome has 166 
also been demonstrated at an inter-species level (59). The similarity of resistance genes 167 
harboured by staphylococci alludes to frequent horizontal gene transfers between species 168 
in vivo (59–63). The mecA gene which confers methicillin resistance in S. aureus and CoNS 169 
is thought to have a chromosomal origin in Staphylococcus sciuri (64). The staphylococcal 170 
chromosome cassette SCCmec is the mobile genetic element which contains the mobile 171 
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mec gene complex amongst staphylococcal species. Whilst a number of SCCmec types 172 
have been catalogued (65) high homology exists between mecA genes, suggestive of a 173 
common origin.  The mecA gene has been investigated as a potential marker of clinical 174 
significance. The mecA homologues mecB, mecC and mecD have also been detected in 175 
staphylococci by WGS (66–70). The mecA gene is strongly associated with nosocomiality in 176 
CoNS with around 80 % of CoNS isolated from hospital sources carrying the gene (33). 177 
However, mecA occurs frequently amongst both infecting and contaminating isolates 178 
(36,42,46,57).  179 
Linezolid is regarded as an important antibiotic in the treatment of methicillin-resistant 180 
staphylococci since it can penetrate tissues and can be administered orally and 181 
intravenously (71). Resistance to linezolid is still relatively rare amongst staphylococci.  It 182 
can be used to treat multidrug-resistant infections (72–74).  Resistance to linezolid may 183 
result from modification of the 23S rRNA part of the 50S subunit (73–76). A number of 184 
point mutations have been identified in 23S rRNA genes which confer resistance to 185 
linezolid in staphylococci (73,75,76) . The plasmid-borne cfr gene produces a ribosomal 186 
RNA large subunit methyltransferase which methylates the adenine at position 2503 in 23S 187 
rRNA and confers resistance to linezolid, chloramphenicol, lincosamides and 188 
streptograminA (73,76) . Mutations in the L3, L4, and L22 ribosomal proteins also confer 189 
resistance to linezolid in staphylococci (73,75,76).  Some strains of S. epidermidis harbour 190 
all 3 mechanisms (23S rRNA mutation, cfr-mediated and ribosomal L-protein mutation) of 191 
linezolid resistance (77,78). Linezolid resistance in S. epidermidis was first reported in 2004 192 
in the USA (32) and has since been reported from Europe, China and Brazil in a number of 193 
different sequence types (73,75,77–81). 194 
The glycopeptides vancomycin and teicoplanin are important antibiotics in the treatment 195 
of methicillin-resistant staphylococci infections. Transfer of the vanA gene from 196 
enterococci to staphylococci has been demonstrated as a feasible mode of acquisition and 197 
a public health concern since expression of the vanA gene changes the dipeptide terminus 198 
from D-alanine-D-alanine to D-alanine-D-lactate to reduce the affinity of vancomycin a 199 
thousand fold (82,83). Glycopeptide resistance in staphylococci may occur as 200 
heteroresistance and reduced susceptibility (83,84). Vancomycin may promote biofilm 201 
formation and cell wall thickening of S. epidermidis which, in turn, reduces the penetration 202 
of vancomycin resulting in heteroresistance (85). Heteroresistance to vancomycin can also 203 
result from mutations in the RNA polymerase B enconding gene rpoB which also confers 204 
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rifampicin resistance (77).  Resistance to vancomycin and teicoplanin has been found in 205 
CoNS isolated from bloodstream infection (BSI) and orthopaedic device-related infection 206 
(ODRI) (77,84,86–89). 207 
The plasmid-borne quaternary ammonium compound (qac)-resistance genes encode 208 
multidrug and multi-antiseptic efflux pumps (90). Different qac genes have been observed 209 
in S. epidermidis, S. haemolyticus and S. hominis (90,91). The presence of qacA has been 210 
shown to correlate with poor treatment outcome of orthopaedic device-related infections 211 
(55). Their presence may enhance persistence at surgical sites despite the use of 212 
antiseptics, thus facilitating accidental introduction onto an implanted prosthesis.  213 
 214 
Coagulase-negative staphylococci as pathogens 215 
Given the spectrum of disease associated with CoNS species two frequent situations in 216 
which determination of pathogenicity has significant clinical implications are in the 217 
diagnosis of BSI and periprosthetic-joint infection (PJI). In both these situations a CoNS 218 
identified in the laboratory may represent a true pathogen but is also frequently present 219 
as a result of sample contamination (92,93). 220 
 221 
Blood stream infection  222 
The great majority of CoNS cultured from blood samples represent sample contaminants 223 
(93,94). However, CoNS are common causes of BSI (95–99). Infections are often catheter-224 
related (99,100). They may arise at the percutaneous entry site with subsequent migration 225 
along the extraluminal catheter surface (101,102). More rarely, they result from 226 
contamination of infusion fluid or haematogenous seeding from other foci (101). 227 
Determination of the significance of CoNS cultured in blood in a susceptible patient is 228 
challenging. Time-to-positivity of blood cultures has been assessed as a potential indicator 229 
of true infection but fundamentally just reflects bacterial density at the time of inoculation 230 
into the bottle and does not usefully differentiate culture contaminants from true 231 
bacteraemia (93,103–105). Clinical management involves catheter removal and 232 
antimicrobial therapy (101,102). Compared with negative blood culture results, false-233 
positive results due to sample contamination are associated with a median increase in 234 
patient bed days of 8 to 12.5 and a median increase in total cost from $8731 to $13116 235 
(106). When CoNS contaminate blood cultures, patients may receive unnecessary 236 
antibiotics. These are frequently parenteral agents such as glycopeptides (93). 237 
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 238 
Periprosthetic-joint infection  239 
Implanted medical devices such as orthopaedic prostheses provide a nidus for bacterial 240 
growth and lack a vascular system that can deliver an immune response or sufficient 241 
antibiotics, making them vulnerable to infection by opportunistic pathogens (107). Biofilm 242 
producing CoNS strains infecting such devices are able to withstand clearance by host 243 
immune system and are relatively non-susceptible to antibiotics (40,108–110). Two studies 244 
investigating the clinical significance of biofilm formation however did not show biofilm 245 
production to be a reliable indicator of significance in CoNS isolated from blood cultures 246 
(111,112). 247 
In clinical practice, periprosthetic-joint infections can be classified according to their 248 
temporal relationship with prosthesis insertion and the presumed mechanism of device 249 
infection. Early (≤3 months post-surgery) and delayed (3 – 24 months post-surgery) 250 
infections are usually associated with direct inoculation at the time of device insertion 251 
(113,114). Late (>24 months post-surgery) infections may result from haematogenous 252 
seeding (113,114) . Staphylococci, including S. epidermidis, are the most commonly 253 
cultured organisms from sampled prosthetic devices at all time points (110,115–119). 254 
The isolation of indistinguishable CoNS isolates from multiple periprosthetic tissue cultures 255 
(taken using separate sterile instruments to avoid cross contamination) is key for 256 
differentiating possible infections from likely contaminants (93,103,112). Determination of 257 
the indistinguishability of organisms relies on the typing method used being able to 258 
robustly determine whether two isolates are indeed the same strain. For the diagnosis of 259 
prosthetic joint infection at hip or knee revision arthroplasty, Atkins et al (120) 260 
demonstrated that detection of indistinguishable organisms from three or more operative 261 
samples was predictive of infection with a sensitivity of 65 % and a specificity of 99.6 %. 262 
These authors used morphotype, biochemical identification of the organism and an 263 
extended antibiogram to distinguish organisms. Isolates of the same phenotype however 264 
may represent genetically different strains (104,121). More recently, the Musculoskeletal 265 
Infection Society (https://www.msis-na.org/) updated their criteria for determining PJI with 266 
a score based on clinical, biochemical, histological and microbiological observations (122). 267 
Recognising that traditional phenotypic approaches to speciation are being replaced by 268 
molecular approaches the guidance suggests consideration of molecular diagnostic testing 269 
directly from samples.  270 
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 271 
Phenotypic and genotypic identification of coagulase-negative staphylococci 272 
Phenotypic methods used for species identification  273 
In the 1970s, arrays based on phenotype (morphological, physiological, biochemical, 274 
antibiotic susceptibility and cell wall composition characteristics) were developed, which 275 
resulted in the discovery and description of new staphylococcal species (123–125). 276 
Subsequently, automated biochemical analysis systems such as VITEK 2 (BioMerieux S.A.) 277 
and Phoenix (Becton Dickinson Biosciences, Sparks, Md.) were developed to allow the 278 
routine determination of antibiotic susceptibilities and species identification of bacteria in 279 
diagnostic laboratories. The development of commercial platforms using Matrix-Assisted 280 
Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry (MALDI-TOF MS)  including 281 
the MALDI Biotyper system (Bruker Daltonique, Wissembourg, France) or the VITEK MS 282 
(bioMérieux, Marcy l'Etoile, France) has revolutionised diagnostic microbiology by 283 
providing a cheap, quick and accurate method for identifying bacteria (126–128).  284 
 285 
Differentiation of strains using phenotypic methods  286 
Phenotypic methods such as antibiotyping and morphotyping are often used in clinical 287 
laboratories as typing methods to distinguish between different strains of a bacterial 288 
species, including staphylococci (4,124,125,129). These methods provide potentially useful 289 
epidemiological information at relatively low additional cost.  However, information 290 
derived from such methods may be misleading as phenotypic characteristics may be 291 
shared by genetically unrelated strains and antibiotic susceptibility may vary within a single 292 
genetic lineage.  Genes that determine antimicrobial resistance or morphology may vary in 293 
their expression and obscure epidemiological links between related isolates (130).  To 294 
avoid such pitfalls, guidance documents have been published regarding the validation and 295 
application of epidemiological typing systems (131,132). 296 
 297 
Characterisation and identification using genotypic methods  298 
16S rRNA gene sequencing has been successfully employed to identify staphylococci and 299 
investigate their phylogeny (133–136). As recently as 2015, this approach led to the 300 
description of the novel taxon Staphylococcus petrasii subspecies pragensis (137). 301 
Identification methods based on RNA polymerase B (rpoB), superoxide dismutase A (sodA) 302 
and elongation factor Tu (tuf) gene sequencing analysis have been proposed (23,138–141) 303 
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but have not replaced 16S rRNA gene sequencing (142). Genotypic methods are reliable 304 
but their routine application in diagnostic settings has been impeded by cost and turn-305 
around-time. 306 
 307 
Differentiation of strains using genotypic methods  308 
Pulsed field gel electrophoresis (PFGE) employs restriction endonuclease enzymes to 309 
cleave chromosomal DNA into fragments which are then subjected to gel electrophoresis 310 
to separate them (143). The fragment size profiles are strain specific and so can be used as 311 
a discriminatory typing method (143) . PFGE as a typing method for S. epidermidis was first 312 
reported in 1992 (144,145). It has been used for hospital outbreak investigation and 313 
comparison of isolates (104,146–148). Although highly discriminatory, PFGE may not allow 314 
differentiation of some genetically distinct isolates (148). Furthermore, differences in PFGE 315 
profile may be misleading if caused by plasmid loss (149), chromosomal rearrangements 316 
(150,151) or changes in the insertion sequence IS256-specific hybridisation patterns (151). 317 
When combined with staphylococcal chromosome cassette SCCmec cassette typing, PFGE 318 
provides results similar to those obtained using multi-locus sequence typing (MLST) (152).  319 
  320 
Multi-locus sequence typing exploits the sequence variation present in specific loci in a 321 
number (six or seven) house-keeping genes (153). Different alleles are assigned a number 322 
so that a sequence type based on the numerical profile of the six or seven loci can be 323 
assigned (153). The pubMLST.org database is the internationally accepted database for 324 
allele sequences. MLST has been used to investigate phylogeny and characterise clinically 325 
important strains of S. aureus, S. epidermidis, S. haemolyticus and S. hominis 326 
(65,118,120,121). The currently accepted scheme for S. epidermidis was developed by 327 
Thomas et al. (154) (Table 2). Clonal complexes were defined as STs which differed by no 328 
more than one allele from at least one other ST (154). The scheme was applied by Miragaia 329 
et al. (155) to a collection of 217 clinical isolates, from which 74 different sequence types 330 
(ST) were identified. A single clonal complex (CC2) accounted for 74 % of isolates; 331 
comprised of 39 STs of which ST2 was the most frequently detected (67/217, 31 %) (155). 332 
An eBURST analysis (which allows inference of the ancestral ST of a clonal complex) 333 
suggested that ST2 was the founding sequence type of the largest clonal complex, 334 
although a later investigation showed ST5 to be the ancestor of the largest clonal complex 335 
(156,157). For S. epidermidis the predominant nosocomial strains ST2, ST5 and ST23 more 336 
frequently harbour virulence-associated genetic elements both within clinical and hospital-337 
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carriage isolates (27,50,155,158,159). ST-based analyses may be able to discriminate 338 
between community and nosocomial isolates but have been of limited value in 339 
discriminating between infecting and contaminating or carriage nosocomial isolates (36). 340 
However, since carriage often precedes infection (160) then identifying particular strains 341 
can be important. O’Connor et al. (161) employed a combination of PFGE and MLST to 342 
identify a single strain of ST2 S. epidermidis that was resistant to linezolid and was 343 
associated with an infection and carriage associated outbreak that was subsequently 344 
limited by enhanced infection control measures.  345 
Multi-locus variable tandem repeat analyses (MLVA) and Multi-locus variable tandem 346 
repeat fingerprinting (MLVF) are similar methods based on the amplification and banding 347 
of several loci of repetitive regions in the genome.  Although less laborious than PFGE, 348 
MLVF failed to resolve the population structure of a collection of S. haemolyticus. 349 
(162,163).    350 
 351 
Genomic investigation of clinically significant coagulase-negative staphylococci 352 
Whole-genome sequencing technologies have the potential to replace and improve upon 353 
traditional phenotypic and genotypic methods performed in diagnostic and public health 354 
laboratories. Short-read (a few hundred base pairs (bp)) sequencing such as Illumina 355 
technology involves the parallel sequencing of short fragments of genomic DNA which 356 
must then be reassembled into longer contigs. Whilst this method may yield higher error 357 
rates than capillary sequencing and struggle to resolve repetitive regions and plasmids it a 358 
high throughput method suitable for diagnostic and public health microbiology. Analysis of 359 
short-read genomic DNA has been applied widely to study transmission and predict 360 
antibiotic resistance of pathogens including Mycobacterium tuberculosis, Neisseria 361 
gonorrhoeae and Staphylococcus aureus (164–166) including sequencing direct from 362 
samples (167,168). Oxford Nanopore technology can produce long reads of around 10,000 363 
bp and lends itself to metagenomic sequencing approaches and for the detection of 364 
bacterial and viral pathogens by directly sequencing clinical samples (169–171). 365 
Many studies have focused on S. aureus, but at the time of writing there are more than 366 
1866 deposits of S. epidermidis sequence read data derived from next-generation 367 
sequencing technologies in the National Center for Biotechnology Information (NCBI) 368 
Sequence Read Archive (SRA) (172,173) providing a rich source of data for researchers to 369 
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survey for lineages or resistance or virulence determinants use as a comparator with their 370 
own isolates (Figure 1).  371 
Research to establish the role of WGS in diagnostic and public health practice for S. aureus 372 
has focused on accurate pathogen identification, reliable prediction of antibiotic 373 
susceptibility, virulence profiling and assessment of transmission (166,174–177). 374 
Furthermore, for S. epidermidis it would be clinically valuable to develop methods that 375 
allow discrimination of infecting and contaminating isolates. 376 
 377 
Pathogen identification  378 
Whole-genome sequencing has the potential to replace MALDI-TOF MS and 16S rRNA gene 379 
sequencing as a tool to identify known and characterise novel staphylococci (69,178). Raw 380 
sequence data can be mapped to a reference genome with software such as SAMtools 381 
(179) and Stampy (180) or compared with a reference genome using the Basic Local 382 
Alignment Search Tool nucleotide (BLASTn) (181) from contigs assembled de novo 383 
assembled with such as Velvet (182). The Average Nucleotide Identity (ANI) method 384 
provides a plausible alternative to DNA-DNA hybridisation technique, the conventional 385 
standard method for measuring the genetic distance between bacteria (183,184). BLASTn 386 
and BLASTn-based ANI methods have been used to identify staphylococci from specimens 387 
routinely sent to clinical microbiology laboratories (185,186).  388 
Velvet constructs de Brujin graphs from k-mers, short subsequences of DNA which overlap 389 
by all but one nucleotide (182).  K-mer-based assembly has been used to identify bacterial 390 
pathogens by directly sequencing clinical samples (167,187). These methods offer the 391 
potential to aid in the diagnosis of culture-negative infection or might even replace 392 
culture-based microbiology. 393 
 394 
Resistance detection  395 
Various platforms that map resistance-associated genes curated in a number of different 396 
databases have been used to predict resistance in Mycobacterium tuberculosis and other 397 
pathogens, including S. aureus (164,175,188). Antibiotic Resistance Gene-ANNOTation 398 
(ARG-ANNOT), Comprehensive Antibiotic Resistance Database (CARD) and Resfinder 399 
employ a BLAST-based method to detect resistance genes in assembled genome 400 
sequences. Resfinder also allows genome assembly from short reads before analysis 401 
(181,189,190). Mykrobe software uses de Brujin graphs to detect resistance genes from 402 
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short reads of S. aureus (191). The Antimicrobial Resistance Identification By Assembly 403 
(ARIBA) also uses short-read data to detect resistance genes (192). Whilst there are several 404 
online sources of AMR elements none so far holds all known resistant elements for the 405 
staphylococci. For routine use such a resource would need to be accessible and contain a 406 
continually updated catalogue of resistance determinants. An ongoing role would exist for 407 
phenotypic investigation of novel determinants and epistatic effects on known 408 
determinants. Such work could be performed in reference laboratories (193).  409 
 410 
Many of the genetic elements associated with resistance in S. aureus are located on mobile 411 
genetic elements or share homology with those observed in CoNS. Indeed there is 412 
evidence that some S. aureus resistance genes originated in CoNS (13,61,194–197). 413 
Modification of methods that allow resistance prediction in S. aureus for application to 414 
CoNS may therefore be a relatively simple process. In addition to detection of known 415 
resistance determinants, Fowler et al. (198) demonstrated a proof-of-principle that the 416 
detection of mutations in the dihydrofolate reductase (dhfr) gene in S. aureus can be used 417 
to predict the effect on the Dhfr enzyme. This in turn provides a measure of the reduction 418 
in the ability of trimethoprim to bind to the affected enzyme, thereby allowing prediction 419 
of minimum inhibitory concentration (MIC) (198). 420 
 421 
Virulence profiling  422 
In theory, the WGS methods developed for resistance gene detection can be applied to 423 
detect virulence-associated genes, although currently there is a lack of information 424 
regarding which genes are important as determinants of virulence in CoNS. Even for S. 425 
aureus, the importance of specific genetic markers which have been linked to specific 426 
disease phenotypes (e.g. Panton-Valentine leucocidin with skin and soft tissue infections, 427 
superantigen toxins with toxic shock syndrome, fibronectin binding protein polymoprhisms 428 
with cardiac device infections) remains unclear (177,199). Cataloguing confirmed and 429 
putative genetic factors associated with virulence could yield valuable information on the 430 
ability of particular strains and species of CoNS to persist on medical devices intra-corpus 431 
(34).  Moreover, bacterial genome-wide association studies (GWAS) comparing isolates 432 
from cases with controls could be powered to detect genetic determinants of specific 433 
phenotypes. However, such studies are challenging because of the requirement to 434 
assemble very large sample sets involving well-defined clinical phenotypes. Moreover, 435 
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features of particular interest such as cell wall adhesins are often encoded in repetitive 436 
regions of the genome, which are poorly assembled from short-read sequencing data. 437 
Nevertheless, S. epidermidis GWAS are beginning to provide some insights. Meric et al. 438 
(200) applied GWAS to S. epidermidis to correlate k-mers with in vitro phenotypes 439 
associated with pathogenicity. The k-mers were present in 61 genes involved in biofilm 440 
formation, cell toxicity, Interleukin-8 response to infection in blood and methicillin 441 
resistance (200) . Such research will enhance our understanding of what differentiates 442 
infecting and commensal bacteria and could ultimately be applied in clinical practice to 443 
direct management decisions in individual patients.  Wirth et al. (201) used a GWAS 444 
approach to investigate the emergence of Staphylococcus capitis NRCS-A clone as an agent 445 
of neonatal sepsis on neonatal intensive care units (ICUs).  The success of the clone could 446 
be attributed to the acquisition of vancomycin resistance.  At a national level, Stenmark et 447 
al. (202) used next-generation sequencing to investigate spread of the S. capitis NRCS-A 448 
clone in Sweden. 449 
 450 
Assessment of transmission  451 
Sequencing-based studies of S. aureus have advanced our understanding of endemic (166) 452 
and epidemic S. aureus transmission (176) and of outbreaks (176,203). Given the clonality 453 
of nosocomially adapted strains of S. epidermidis, S. haemoloyticus and S. hominis  454 
(27,58,73,78,204,205) and the poor resolution of conventional typing methods, WGS is 455 
likely to improve understanding of clonal spread, outbreaks and endemicity of CoNS. In 456 
one study 5/9 isolates of a single clonal linage of S. epidermidis were associated with 457 
neonatal sepsis (186). The nine isolates were highly related (diversity ranged from 0 to 18 458 
SNPs between any two isolates) and all from patients with overlapping stay in the ward 459 
suggesting common ancestry of a virulent strain (186). At a larger scale WGS was used to 460 
resolve two distinct lineages of ST2 that would be indistinguishable by MLST, alongside a 461 
lineage of ST23 that have spread globally and show genotypic and phenotypic resistance to 462 
rifampicin, fusidic acid and aminoglycosides (85). Lazaris et al. (206) employed WGS to 463 
characterise an outbreak of linezolid resistant MRSE on an ICU. Although 13 isolates were 464 
indistinguishable by MLST and SCCmec typing, 12 isolates differed by 1 - 52 SNPs and were 465 
cfr-negative whilst one differed from them by 202 – 223 SNPs and harboured a novel cfr-466 
positive plasmid (206) . This highlights the resolution afforded by WGS and demonstrates 467 
that both strain and plasmid surveillance can be performed using a single assay.  468 
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 469 
Discrimination of infection from sample contamination  470 
Accidental introduction of organisms to an indwelling device such as a prosthetic joint or 471 
venous catheter is thought to account for many CoNS infections. As such infections are 472 
associated with nosocomial and commensal strains rather than with distinctive primary 473 
pathogens it is difficult to discriminate between infecting and contaminating isolates 474 
(36,42,207). Genome-wide linkage studies have substantially failed to identify simple 475 
genotype-phenotype relationships in staphylococcal infection. However, the study of 476 
sequential isolates has revealed the nature of within-host adaptations that accompany 477 
invasive S. aureus disease. Common mutations observed in invasive S. aureus undergoing 478 
within-host evolution (208) suggest that it may be possible to differentiate colonising and 479 
infecting staphylococci by detection of such mutations. Another diagnostic approach might 480 
be to measure the genetic relatedness of multiple isolates. In S. aureus infection it has 481 
been shown that a small subset of donor bacteria diversifies in the recipient host (209). 482 
The accumulation of point mutations over the course of time during chronic CoNS 483 
infection of orthopaedic devices would be expected to present a characteristic cloud of 484 
diversity that could be used to distinguish infection from sample contamination (Figure 2). 485 
Where multiple strains of a CNS species are inoculated into a surgical wound, 486 
discrimination down to the level of point mutations would allow isolates with different 487 
ancestors to be differentiated. 488 
 489 
Investigation of within-host adaptation  490 
During the course of an infection, a pathogen may undergo within-host evolutionary 491 
adaptive change associated with changes in virulence and tolerance to the host immune 492 
system or antimicrobial therapy. Whole genome sequencing of sequential isolates of S. 493 
epidermidis obtained from a pacemaker-associated infective endocarditis allowed 494 
investigation of genetic changes associated with increased biofilm formation, reduced 495 
growth and resistance to rifampicin over time (210). Similar studies of S. aureus 496 
endocarditis isolates have shown an accumulation of point mutations that lead to 497 
increased resistance to vancomycin following exposure (211,212).  498 
  499 
Limitations of whole-genome sequencing 500 
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The prospect of adopting WGS in routine diagnostic microbiology to investigate CoNS 501 
infection is a tantalising one but several limitations currently impede the widespread 502 
adoption of WGS.  A primary issue is cost. The sequencing instrument, reagents and the 503 
necessary laboratory and computational infrastructure are currently more costly than the 504 
equipment and consumables required for conventional culture-based techniques. 505 
Furthermore, specialist expertise is required to perform and analyse WGS. Whole genome 506 
sequencing-associated costs generally necessitate the batching of samples resulting in 507 
increased turn-around times that are unsuitable for diagnostic service.  Unlike 508 
conventional phenotypic methods used to detect antimicrobial resistance, WGS-based 509 
methods require prior knowledge of the genetic basis for resistance and may fail to detect 510 
a hitherto unknown resistance element. Phenotypic methods also allow the observation of 511 
MIC creep which may not be detected by genotyping.  Another limitation is the current 512 
absence of a widely accepted international standard for the interpretation of WGS for 513 
diagnostic purposes.  Nevertheless, all of these limitations may eventually be overcome.  514 
 515 
Conclusion 516 
A significant body of research literature already exists as a result of genome-based studies 517 
of CoNS. This will grow as sequencing becomes more widely available. Genomic 518 
investigation of bacteria can provide information about genetic diversity, of population 519 
structure locally and globally and can provide insights into the natural history of 520 
colonisation and infection. Such information can be used to develop methods to identify 521 
and compare the relatedness of isolates, detect and investigate outbreaks, study 522 
transmission and predict antimicrobial resistance. These approaches have been applied to 523 
S. aureus (133,140–143,171,176–178) and the potential exists for their application to 524 
CoNS. WGS may eventually replace culture-dependent methods (135,179,180).  525 
 526 
Coagulase-negative staphylococci are important causes of nosocomial infection. Although 527 
less virulent than S. aureus, nosocomial CoNS are often multi-resistant, necessitating the 528 
use of second line antibiotics. Infections are often associated with indwelling medical 529 
devices. Difficulties in discriminating between infecting and contaminating isolates can 530 
lead to unnecessary antibiotic therapy and device removal with impacts on patient care 531 
and antibiotic resistance. Genome sequencing lends itself to the detection of post hoc 532 
signals of infection since it can identify subtle changes in the genome, such as point 533 
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mutations acquired over time following inoculation or adaptive changes caused by 534 
environmental pressures (208,211–213).  535 
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No. of Isolates 678 499 499 944 239 450 369 212 83 601 167 494 200 98 51 208 Mean% 
S. epidermidis 75 65 58 41 50 50 56 71 34 68 13 67 44 24 67 86 54.3 
S. 
haemolyticus 7 13 9 15 10 15 5 2 13 7 72 12 12 37 12 11 15.8 
S. hominis 5 7 12 5 12 11 18 4 2 8 6 9 9 3     6.9 
S. capitis 2 4   5   4 3 6 10 5 1 1 8 12 4   4.1 
S. warneri 3 4 2 3   4 4 7 1 5 1 2 4   8 2 3.1 
S. lugdunensis   3   2   2   3 13 1 1 3 9       2.3 
S. xylosus           4     6     1 5 13     1.8 
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S. caprae       14       2   1   1     6   1.5 
S. 
saprophyticus 1 1 1 5   6 5           3     1 1.4 
S. simulans 1 2   6   2 1 1     2 1 2 1     1.2 
S. cohnii   1 1   6 1       3   1   8     1.3 
S. schleiferi                 12     1         0.8 
S. pasteuri               2             2   0.3 
S. auricularis                         1       0.1 
Not 




Table 1. Percentage of CoNS species isolated from clinical samples 1983 – 2015 (Adapted from Piette & Verschraegen G [23] & Becker et al. [34])  
CS = Clinical specimen, BSI = Bloodstream infection, BJI = Bone & joint infection, PJI = Prosthetic joint infection, CRBI = Catheter-related bloodstream infection, CAPD = Continuous 








S. aureus arcC aroE glpF gmk pta tpi yqiL 
S. epidermidis arcC aroE gtr mutS pyrR tpiA yqiL 
S. haemolyticus arcC SH_1200 hemH leuB SH1431 cfxE Ribose_ABC 










Figure 1. Number of Staphylococcus epidermidis assembled genomes released in the NCBI Genome database 
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Figure 2. Working hypothesis of the difference in diversity between monoclonal contamination, monoclonal 
infection and polyclonal infection. The thick horizontal bars represent the inoculation event either during 
implantation (for infection) or specimen explantation/processing (for contamination). Adapted from Young et al. 
(208). 
